US DEA Facing Fresh Lawsuits After Denying Psilocybin Waiver, Rescheduling Request
For more than a year, a palliative care specialist has been fighting to be granted permission by the U.S. Drug Enforcement Administration (DEA) to administer psilocybin to his patients. Dr. Sunil Aggarwal had requested a federal waiver under the Right to Try statute, which would have allowed him to administer the psychedelic to his patients with terminal illnesses. Aggarwal explained that Right to Try laws clearly stipulate that severely ill individuals qualified for investigational drugs, including psychedelics. However, the DEA rejected the request as well as a petition the doctor filed to reschedule psilocybin. In its argument, the federal agency…
